Bulgaria's public health insurer. It publishes reports of the medicines for hospitals that it pays for outside the price of clinical pathways, and a list of anti-tumour medicines, and grants expensive medicines after an expert assessment.
The National Health Insurance Fund (Национална здравноосигурителна каса, НЗОК) publishes lists of the medicines it pays for, including medicinal products used in hospital care, and reports on hospital medicines paid outside the value of clinical pathways and outpatient procedures (извън стойността на КП/АПр), by region, hospital, diagnosis code and ATC code. Under the heading of medicines by clinical pathway and outpatient procedure it publishes a list of anti-tumour medicines and a list of medicines for oncological and onco-haematological diseases for which forming a remainder is allowed. Expert assessments for granting expensive medicines are made under Article 78, point 2, of the Health Insurance Act, with requirements set out per disease. The two pages read do not say which cancer medicines are paid outside the pathway price. The coordinates are an approximate Sofia city point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/